Design for Recoverability, Not Just Speed, in Genomics Automation

In high throughput clinical genomics, we celebrate cycle times and samples per day. The metric I care about more is recoverability. When a liquid handler hiccups mid library prep or a thermocycler throws a temperature fault, can you contain the failure to a few wells and restart the run in minutes without compromising traceability? In a CLIA/CAP lab, that saves more patient reports than shaving 2 minutes from a protocol.

What has worked for us: smaller independent batches with in line QC gates; idempotent steps that are safe to re run; plate map snapshots and reagent lot capture at every checkpoint; explicit pause and resume states in the LIMS to rebuild deck state. We added dry run simulators to catch deck conflicts and made error handling consistent across Hamilton and Tecan so techs get the same plain language prompts and recovery scripts.

The result was fewer full plate write offs and faster MTTR when things go sideways, which increased true throughput more than a speed tweak. How do you quantify the ROI of recoverability, and what patterns make your NGS workflows restartable without risking contamination or data drift?